A Van Hoof

628 total citations
9 papers, 221 citations indexed

About

A Van Hoof is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, A Van Hoof has authored 9 papers receiving a total of 221 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Pulmonary and Respiratory Medicine, 3 papers in Oncology and 2 papers in Molecular Biology. Recurrent topics in A Van Hoof's work include Acute Myeloid Leukemia Research (2 papers), Lymphoma Diagnosis and Treatment (2 papers) and Chronic Myeloid Leukemia Treatments (2 papers). A Van Hoof is often cited by papers focused on Acute Myeloid Leukemia Research (2 papers), Lymphoma Diagnosis and Treatment (2 papers) and Chronic Myeloid Leukemia Treatments (2 papers). A Van Hoof collaborates with scholars based in Belgium, Switzerland and Italy. A Van Hoof's co-authors include Peter Vandenberghe, Lucienne Michaux, G. Verhoef, D. Gary Gilliland, M. Boogaerts, Dominik Selleslag, Pierre Zachée, A Hagemeijer, Marie Maerevoet and Peter Marynen and has published in prestigious journals such as Blood, Annals of Oncology and Molecular Cancer.

In The Last Decade

A Van Hoof

9 papers receiving 211 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
A Van Hoof Belgium	8	117	86	63	61	49	9	221
D. Schaumann Germany	6	93 0.8×	171 2.0×	26 0.4×	36 0.6×	57 1.2×	12	308
John McLaren United Kingdom	8	177 1.5×	152 1.8×	40 0.6×	16 0.3×	83 1.7×	10	292
C. J. Kooiker Netherlands	6	86 0.7×	116 1.3×	23 0.4×	75 1.2×	18 0.4×	7	310
Margaret Michalska United States	9	193 1.6×	47 0.5×	82 1.3×	14 0.2×	58 1.2×	22	291
C. Schaufelberger Sweden	7	142 1.2×	110 1.3×	19 0.3×	13 0.2×	48 1.0×	9	215
John P. Farnen United States	9	42 0.4×	32 0.4×	51 0.8×	84 1.4×	53 1.1×	16	265
H Pellet France	8	131 1.1×	210 2.4×	9 0.1×	21 0.3×	59 1.2×	39	312
Joseph Lambert France	6	191 1.6×	18 0.2×	58 0.9×	13 0.2×	62 1.3×	21	260
H Naseem United Kingdom	6	131 1.1×	19 0.2×	21 0.3×	90 1.5×	20 0.4×	8	277
Sylvie Hoang France	9	333 2.8×	14 0.2×	84 1.3×	26 0.4×	38 0.8×	12	362

Countries citing papers authored by A Van Hoof

Since Specialization

Citations

This map shows the geographic impact of A Van Hoof's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A Van Hoof with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A Van Hoof more than expected).

Fields of papers citing papers by A Van Hoof

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A Van Hoof. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A Van Hoof. The network helps show where A Van Hoof may publish in the future.

Co-authorship network of co-authors of A Van Hoof

This figure shows the co-authorship network connecting the top 25 collaborators of A Van Hoof. A scholar is included among the top collaborators of A Van Hoof based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A Van Hoof. A Van Hoof is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

L’Abbate, Alberto, Doron Tolomeo, Angelo Lonoce, et al.. (2015). t(15;21) translocations leading to the concurrent downregulation of RUNX1 and its transcription factor partner genes SIN3A and TCF12 in myeloid disorders. Molecular Cancer. 14(1). 211–211. 14 indexed citations

Vandenberghe, Peter, Iwona Włodarska, Lucienne Michaux, et al.. (2004). Clinical and molecular features of FIP1L1-PDFGRA (+) chronic eosinophilic leukemias. Leukemia. 18(4). 734–742. 116 indexed citations

Aleman, Berthe M.P., M. Henry‐Amar, Umberto Tirelli, et al.. (2001). Involved field irradiation (IFRT) does not improve outcome in patients with stage III/IV Hodgkin's lymphoma (HL) in complete remission after MOPP/ABV (M/A): Results of the randomised EORTC trial 20884. Blood. 98(11). 6 indexed citations

Raemaekers, John, M. Henry‐Amar, A. Pinna, et al.. (1997). . Annals of Oncology. 8(1+). 111–114. 7 indexed citations

Raemaekers, John, M Burgers, M. Henry‐Amar, et al.. (1997). Patients with stage III/IV Hodgkin's disease in partial remission after MOPP/ABV chemotherapy have excellent prognosis after additional involved-field radiotherapy: interim results from the ongoing EORTC-LCG and GPMC phase III trial. The EORTC Lymphoma Cooperative Group and Groupe Pierre-et-Marie-Curie.. PubMed. 8 Suppl 1. 111–4. 16 indexed citations

Vleymen, Betty Van, I. Dehaene, A Van Hoof, & G Pattyn. (1987). Cerebral venous thrombosis in paroxysmal nocturnal haemoglobinuria.. PubMed. 87(2). 80–7. 7 indexed citations

Louwagie, A., Cristina Mecucci, A. Criel, A Van Hoof, & Herman Van den Berghe. (1987). Variant translocation t(15q;17q) accompanying a promyelocytic accelerated phase of Ph-positive chronic myeloid leukemia. Cancer Genetics and Cytogenetics. 28(2). 349–352. 14 indexed citations

Verhaeghe, Raymond, A Van Hoof, & G Beyens. (1981). Controlled Trial of Suloctidil in Intermittent Claudication. Journal of Cardiovascular Pharmacology. 3(2). 279–286. 18 indexed citations

Verstraete, Matthieu J., et al.. (1977). Double-Blind Trials with Ethamsylate, Batroxobin or Tranexamic Acid on Blood Loss After Adenotonsillectomy. Acta Clinica Belgica. 32(2). 136–141. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact